CLOSE MENU
At a reception held in his honor on Monday, CUNY SPH Professor Jeffrey Lazarus was presented with the American Liver Foundation (ALF) Distinguished Scientific Achievement Award for his work to combat viral hepatitis and metabolic dysfunction associated steatotic liver disease (MASLD).
The prestigious award honors a scientist who has made a major contribution to liver disease research in basic science or in its application towards the prevention, treatment or cure of liver disease.
Dr. Lazarus’s research is focused on expanding access to care within health systems, particularly people-centered healthcare and enhanced quality of life; improving outcomes for pressing, stigma-inducing infectious diseases confronting people around the world; and building collaborative, multidisciplinary teams generating knowledge applicable to multiple disease areas and across systemic risk.
“For me, receiving the Distinguished Scientific Achievement Award marks an important expansion of the field to elevate public health and policy,” said Dr. Lazarus. “I dedicate this award to my team and to my many hundreds of co-authors of multiple global consensus statements, policy reviews, guidelines, studies and real-world fieldwork. Together, we have expanded the community of practice and enhanced policy. Next? We save even more lives.”
A member of numerous academic and professional committees dedicated to global health issues, Dr. Lazarus is the author of 400 publications including the landmark nonalcoholic fatty liver disease public health consensus statement, the new steatotic liver disease (formerly known as fatty liver disease) nomenclature, which was published in leading professional journals, and the global research and action priorities to set the first global action plan for the field of steatotic liver disease.
“We are immensely proud that Dr. Lazarus has been honored in this way for his hard work to advance liver health,” says CUNY SPH Dean Ayman El-Mohandes. “We have no doubt that he will continue to produce groundbreaking research on this and many other pressing public health challenges.”
